Has Mohammad Khera received payments from drug or device companies?

Yes. Drug and device makers reported $3,541 in general payments to Mohammad Khera across 151 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mohammad Khera did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mohammad Khera come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mohammad Khera

Pediatrics · Winsted, CTNPI 1073570784

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,521 of the $3,541 with a category attached, or 71.2%. 13 manufacturers reported payments, led by Corium, LLC at 36.6% of the total. Reporting peaked in 2020 at $1,231 and has fallen 65.0% since, to $431 in 2025. Among pediatrics clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,541in general payments, 2019–2025

Across 151 payments — averaging $23.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Corium, LLC$1K
Genentech USA, Inc.$1K
Takeda Pharmaceuticals U.S.A., Inc.$295
Tris Pharma Inc$269
Pfizer$204
Sobi, Inc$110
plus $224 from 7 others

What the payments were for

Consulting fees$1,02029%
Food & beverage$2,52171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Corium, LLC	80	$1,297
Genentech USA, Inc.	8	$1,142
Takeda Pharmaceuticals U.S.A., Inc.	21	$295
Tris Pharma Inc	14	$269
Pfizer	10	$204
Sobi, Inc	7	$110
Ironshore Pharmaceuticals Inc.	4	$69
Supernus Pharmaceuticals, Inc.	2	$49
GSK	1	$25
Boston Scientific	1	$24
Sanofi Pasteur Inc.	1	$23
Collegium Pharmaceutical, Inc.	1	$20
Shire North American Group Inc	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Xofluza$1,020

How this compares

$3,541 in reported general payments places this provider in the 95th percentile of 681 pediatrics providers in Connecticut.

See all pediatrics providers in Connecticut →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Levetiracetam	11	$793
Guanfacine Hcl	11	$530
Trazodone Hcl	11	$47
Risperidone	11	$47
Clonidine Hcl	11	$14
Sertraline Hcl	11	$13

Paid to pharmacies, not to this prescriber.

Other pediatrics in Winsted

Alan MuneyDarien$369K
Amanda ZuseHartford$45K
Nicholas BennettHartford$37K
William ZempskyHartford$35K
Eugene ShapiroNew Haven$15K
John DubazDarien$9K
Anthony WayneAnsonia$7K
Kweku SamMiddlebury$6K
Robert LavalleeAnsonia$6K
Samantha LeeWest Hartford$5K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →